RVL Pharmaceuticals (RVLP) Short Interest Ratio & Short Volume

Short interest is the volume of RVL Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 3,280,000 shares of RVLP short. 4.03% of RVL Pharmaceuticals' shares are currently sold short. Learn More on RVL Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.03% of RVL Pharmaceuticals' floating shares are currently sold short.

RVL Pharmaceuticals saw a increase in short interest in September. As of September 30th, there was short interest totaling 3,280,000 shares, an increase of 25.7% from the previous total of 2,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

RVL Pharmaceuticals currently has issued a total of 111,410,000 shares. Some of RVL Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RVL Pharmaceuticals currently has a public float of 81,350,000 shares.

4.03% of RVL Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to RVL Pharmaceuticals: Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), Mainz Biomed (2.34%), NLS Pharmaceutics Ltd. (1.54%), Pharvaris (0.10%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (0.07%), American Oncology Network, Inc. (1.02%), Societal CDMO, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.11 billion), Charter Communications, Inc. ($3.68 billion), T-Mobile US, Inc. ($3.56 billion), Canadian Natural Resources Limited ($3.54 billion), Occidental Petroleum Co. ($3.02 billion), Tractor Supply ($2.29 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($1.91 billion), Celsius Holdings, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.76 billion). View all of the most shorted stocks.

Short selling RVLP is an investing strategy that aims to generate trading profit from RVL Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for RVL Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RVLP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVLP, twice per month. The most recent reporting period available is September, 30 2023.